|Mr. Florian Schonharting M.Sc. (Econ)||Co-Founder & Chairman||N/A||N/A||1969|
|Dr. Claus Bo Søndergaard Svendsen M.D., Ph.D.||Chief Exec. Officer||N/A||N/A||1977|
|Mr. Thomas Carbone||VP of Fin. & Controller||N/A||N/A||1957|
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.
Forward Pharma A/S’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.